[11] For anyone who relies on anti-inflammatories for chronic pain or recovery, this is a significant findingaddressing the side effects of the very drugs commonly used for the same conditions BPC-157 targets
Inaccurate, unreliable, and ultimately worthless data
4.2 Chemicals Mitoquinone Mesylate (MitoQ, MQ) was purchased from MedChemExpress (#HY-100116A), and Diphenyleneiodonium chloride (DPI) from Enzo Life Sciences (#BML-CN240-0010)
Risk Categories Lower risk individuals include those under 40 without personal or significant family cancer history who are current on screening and using BPC-157 for significant healing needs
50 units = 5 mg
Injection sites are chosen based on the indication: near the injury site for musculoskeletal applications, or at a standard subcutaneous site (abdomen, thigh, upper arm) for systemic and GI applications